The hemagglutinin-neuraminidase gene of Newcastle Disease Virus: A powerful molecular adjuvant for DNA anti-tumor vaccination. Aug 2010 - :1873-2518 [PMID:20709006] [Ni J] [Schirrmacher V] [Fournier P]
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination. Aug 2010 - Proc. Natl. Acad. Sci. U.S.A.; 107(31):1091-6490 [PMID:20631300] [Van Tendeloo VF] [Van de Velde A] [Van Driessche A] [Cools N] [Anguille S] [Ladell K] [Gostick E] [Vermeulen K] [Pieters K] [Nijs G] [Stein B] [Smits EL] [Schroyens WA] [Gadisseur AP] [Vrelust I] [Jorens PG] [Goossens H] [de Vries IJ] [Price DA] [Oji Y] [Oka Y] [Sugiyama H] [Berneman ZN]
Advances in cellular therapy for the treatment of thyroid cancer. Jul 2010 - J Oncol; 2010:1687-8469 [PMID:20671939] [Papewalis C] [Ehlers M] [Schott M]
Tumor antigen presentation by dendritic cells. Jul 2010 - Crit. Rev. Immunol.; 30(4):1040-8401 [PMID:20666707] [Petersen TR] [Dickgreber N] [Hermans IF]
Human myeloid dendritic cells for cancer therapy: does maturation matter? Jul 2010 - Vaccine; 28(32):1873-2518 [PMID:20665974] [Skalova K] [Mollova K] [Michalek J]
Prostate cancer as a model for tumour immunotherapy. Jul 2010 - Nat. Rev. Immunol.; 10(8):1474-1741 [PMID:20651745] [Drake CG]
Global sensitivity analysis and model-based reactive scheduling of targeted cancer immunotherapy. Jul 2010 - BioSystems; 101(2):1872-8324 [PMID:20639123] [Kiran KL] [Lakshminarayanan S]
Biological Rationales and Clinical Applications of Temperature Controlled Hyperthermia - Implications for Multimodal Cancer Treatments. Jul 2010 - :1875-533X [PMID:20629627] [Schildkopf P] [Ott OJ] [Frey B] [Wadepohl M] [Sauer R] [Fietkau R] [Gaipl US]
Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells. Jun 2010 - Ann. Hematol.; 89(8):1432-0584 [PMID:20238114] [Yang DH] [Kim MH] [Hong CY] [Lee YK] [Jin CJ] [Pham TN] [Ahn JS] [Bae WK] [Kim YK] [Chung IJ] [Kim HJ] [Kalinski P] [Lee JJ]
Dendritic cells fused with allogeneic hepatocellular carcinoma cell line compared with fused autologous tumor cells as hepatocellular carcinoma vaccines. Jun 2010 - Hepatol. Res.; 40(5):1386-6346 [PMID:20374301] [Yang JY] [Cao DY] [Ma LY] [Liu WC]
Immunotherapy of hepatocellular carcinoma. Jun 2010 - Expert Rev Gastroenterol Hepatol; 4(3):1747-4132 [PMID:20528121] [Korangy F] [Höchst B] [Manns MP] [Greten TF]
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Mai 2010 - :1474-5488 [PMID:20434400] [Issels RD] [Lindner LH] [Verweij J] [Wust P] [Reichardt P] [Schem BC] [Abdel-Rahman S] [Daugaard S] [Salat C] [Wendtner CM] [Vujaskovic Z] [Wessalowski R] [Jauch KW] [Dürr HR] [Ploner F] [Baur-Melnyk A] [Mansmann U] [Hiddemann W] [Blay JY] [Hohenberger P]
Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial. Apr 2010 - :1477-2566 [PMID:20429791] [Trepiakas R] [Berntsen A] [Hadrup SR] [Bjørn J] [Geertsen PF] [Straten PT] [Andersen MH] [Pedersen AE] [Soleimani A] [Lorentzen T] [Johansen JS] [Svane IM]
Cutting Edge: Delay and Reversal of T Cell Tolerance by Intratumoral Injection of Antigen-Loaded Dendritic Cells in an Autochthonous Tumor Model. Apr 2010 - :1550-6606 [PMID:20427765] [Higham EM] [Shen CH] [Wittrup KD] [Chen J]
The anti-tumor effect of Newcastle disease virus HN protein is influenced by differential subcellular targeting. Apr 2010 - Cancer Immunol. Immunother.; 59(7):1432-0851 [PMID:20130861] [Sui H] [Bai Y] [Wang K] [Li X] [Song C] [Fu F] [Zhang Y] [Li L]
